LK
ETON icon

Lumbard & Kellner’s Eton Pharmaceutcials ETON Stock Holding History

Lumbard & Kellner’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.37M Sell
175,909
-2
-0% -$59 1.93% 18
2026
Q1 		$4.34M Buy
175,911
+967
+0.6% +$16.9K 1.5% 24
2025
Q4 		$2.96M Sell
174,944
-1,356
-0.8% -$23.9K 1.04% 37
2025
Q3 		$3.83M Buy
+176,300
New +$2.93M 1.41% 29

Other funds holding ETON

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return
ACA
Anchor Capital Advisors Boston, Massachusetts $3.56B AUM 21.74% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Lumbard & Kellner's ETON Position: Q2 2026 in Review

Lumbard & Kellner reduced its Eton Pharmaceutcials (ETON) stake by 0% in Q2 2026, selling an estimated $59 and leaving 175,909 shares worth $6.37M. The position accounts for 1.93% of the portfolio, ranked #18.

Lumbard & Kellner first reported a position in ETON in Q3 2025 and has held it in 4 quarters since. 59 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

  • Lumbard & Kellner held 175,909 shares of Eton Pharmaceutcials worth $6.37M as of Q2 2026.
  • Lumbard & Kellner sold 2 Eton Pharmaceutcials shares in Q2 2026, an estimated $59.
  • Eton Pharmaceutcials made up 1.93% of Lumbard & Kellner's portfolio in Q2 2026, its #18 holding.
  • Lumbard & Kellner first reported a position in Eton Pharmaceutcials in Q3 2025 and has held it in 4 quarters since.
  • 59 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on Lumbard & Kellner's 13F filing for Q2 2026, filed 6 Aug 2026.